Details
Stereochemistry | MIXED |
Molecular Formula | C23H32N2O3 |
Molecular Weight | 384.5118 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(CN1CCN(CC(O)C(OC)C2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=VSTNNAYSCJQCQI-UHFFFAOYSA-N
InChI=1S/C23H32N2O3/c1-27-22(19-9-5-3-6-10-19)18-25-15-13-24(14-16-25)17-21(26)23(28-2)20-11-7-4-8-12-20/h3-12,21-23,26H,13-18H2,1-2H3
Molecular Formula | C23H32N2O3 |
Molecular Weight | 384.5118 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Zipeprol is disubstituted piperazine that is marketed as a non-opioid antitussive in Europe, Asia, and South America. Zipeprol is not available in the United States or Canada and has been discontinued in Europe. Zipeprol is still available in some countries in Asia and South America. Zipeprol was demonstrated to have anticough effects in animal models, to be active as a blocker of histamine and cholinergic function, to be a potent local anesthetic and to possess bronchiospasmolytic actions. it had no remarkable cardiovascular or gastrointestinal actions in the rat or dog in comparison to codeine.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:50:02 UTC 2023
by
admin
on
Fri Dec 15 15:50:02 UTC 2023
|
Record UNII |
G5MUV8139H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9873
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
||
|
NCI_THESAURUS |
C66917
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
||
|
WHO-VATC |
QR05DB15
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
||
|
WHO-ATC |
R05DB15
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
36910
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
DTXSID00865732
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
m11640
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2105497
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
C013341
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
SUB00167MIG
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
DB13564
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
3212
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
34758-83-3
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
2864
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
ZIPEPROL
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
C66698
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
100000078770
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
252-191-7
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
G5MUV8139H
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | |||
|
39969
Created by
admin on Fri Dec 15 15:50:02 UTC 2023 , Edited by admin on Fri Dec 15 15:50:02 UTC 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Route of Elimination | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||